EN DE
Watch Century Sage Scientific for free: once a week we email you where price and fair value stand.
Data-driven stock valuation

Century Sage Scientific (1450) fair value: what the stock is really worth

As of Nov 17, 2026: fair value (intrinsic value) of Century Sage Scientific stock HK$1.14, price HK$0.38, upside +200.0%, quality 71 out of 100. Rating: strongly undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology HK · Based in China · ISIN KYG202281054

CS Century Sage Scientific logo Thin data Nov 18, 2026

Century Sage Scientific

1450 · HK

Cheap (67% below fair value) and solid company, but falling price: meets 2 of 3 rules.

Follow free in the weekly email
Fair value HK$1.14 · Strongly undervalued 
Quality 71/100 
Low debt 
Generates free cash flow 
11.8% dividend yield · Well covered
Ranks above peers (14/14) 
Last quarter vs. a year ago: revenue +25%, profit +47%. 
Mixed Growth (revenue 5y +57.5 %/yr in CNY) 
Thin margins · 7.3% net margin (TTM) 
Moderate moat 61/100 · thin data
Falling price (downtrend) 
Thin data 
Watch Century Sage Scientific for free: once a week we email you where price and fair value stand. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$4.03 HK$0.2061 Fair Value HK$1.14 Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 18, 2026.

How to read this chart

60‑month range HK$0.2061 – HK$4.03 · fair‑value band HK$0.7953 – HK$1.48 · the HK$0.3800 price screens below the HK$1.14 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 18, 2026.

Follow Century Sage Scientific in your weekly email

Every Wednesday you see whether Century Sage Scientific is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Be Friends Holding Limited, an investment holding company, provides all-media services in the People's Republic of China.

Show moreShow less

The company offers new media services, such as marketing services to the merchants for the livestream e-commerce on the e-commerce platforms; and application solutions, including design, implementation, and support services, as well as offers broadcasting equipment.

It also sells self-developed equipment and related products; and provides system maintenance services comprising maintenance, training, and other supporting services. The company serves media platforms, industrial customers, and broadcasters.

The company was formerly known as Century Sage Scientific Holdings Limited and changed its name to Be Friends Holding Limited in July 2023. Be Friends Holding Limited was founded in 2007 and is headquartered in Hangzhou, the People's Republic of China.

Stock analysis

Century Sage Scientific (1450) currently trades at HK$0.3800, while our model-based Fair Value estimate is HK$1.14, implying the stock looks roughly 67% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of HK$4.13 per share, and 23 of the 24 models we run sit above the HK$0.3800 price.

Bear case: the Asset-Based group reads lowest at HK$0.2100, and 1 of the 24 models stay below the price. Data coverage for this calculation is low.

Scenario range: HK$0.7953 (bear) to HK$1.48 (bull), the price of HK$0.3800 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 71/100 (solid quality), in the Technology sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Century Sage Scientific reported revenue of 1.5B CNY in FY2025 versus 203M CNY in FY2021, a compound +64.5%/yr. Reported net income was 90.2M CNY in FY2025.

Key figures

Market cap HK$534M (≈ $68.0M) Micro · P/E ratio 5.1 · P/S ratio 0.31 · Dividend yield 11.8% · Net margin 6.1% · Return on equity 23.1% · Return on assets (EBIT) 6.5% (5-year average) · Operating margin 14.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 61 out of 100 (low confidence).

What moves the price

The share trades about 66% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at 10% fair-value upside, at 200%, 1450 screens cheaper than that median.

Fair Value models

Bear HK$0.7953 Fair Value HK$1.14 Bull HK$1.48
Price HK$0.3800 · Upside +200.0%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF HK$3.42 HK$4.82 HK$8.41 78
Growth DCF HK$3.25 HK$5.00 HK$7.87 77
Residual Income HK$0.4100 HK$0.5000 HK$0.7000 76
All 24 models by family
DCF Models
FCF DCF HK$3.42 HK$4.82 HK$8.41 78
Owner Earnings HK$1.90 HK$3.38 HK$5.90 74
5Y Revenue Exit HK$2.08 HK$3.03 HK$4.80 72
5Y EBITDA Exit HK$2.19 HK$3.26 HK$5.17 74
5Y P/E Exit HK$2.20 HK$3.56 HK$5.22 70
10Y Revenue Exit HK$2.53 HK$3.87 HK$5.10 67
10Y EBITDA Exit HK$2.63 HK$4.04 HK$6.34 67
10Y P/E Exit HK$2.63 HK$4.06 HK$6.30 63
Earnings-Based
Graham-Dodd HK$0.5100 HK$3.58 HK$5.03 63
Lynch FV HK$1.09 HK$1.55 HK$2.02 61
PEG = 1.0 HK$1.09 HK$1.55 HK$2.02 57
EPV HK$0.8100 HK$0.8700 HK$0.9100 74
Multiples
P/E Multiple HK$1.25 HK$1.66 HK$2.08 63
P/S Multiple HK$0.9600 HK$1.28 HK$1.61 58
P/B Multiple HK$0.6400 HK$0.8600 HK$1.07 55
EV/EBIT HK$1.48 HK$1.91 HK$2.33 66
EV/EBITDA HK$1.43 HK$1.84 HK$2.25 67
EV/Revenue HK$1.18 HK$1.59 HK$2.00 54
Asset-Based
NCAV (Graham) HK$0.1400 HK$0.2100 HK$0.2600 55
Growth DCF
Growth DCF HK$3.25 HK$5.00 HK$7.87 77
Rev-Margin DCF HK$2.08 HK$3.25 HK$4.98 72
Economic Profit
Residual Income HK$0.4100 HK$0.5000 HK$0.7000 76
ROIC Compounder HK$0.8800 HK$1.02 HK$1.18 72
Growth Earnings
Growth-Adj P/E HK$1.50 HK$2.15 HK$2.79 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 71/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 72
How much profit the company makes from its sales and capital
Quality Growth 57
Are margins and returns getting better?
Cashflow 95
Do the profits arrive as real cash?
Financial strength 89
Debt, balance sheet and risk of trouble
Investment 33
Does it invest with discipline instead of growing at any price?
Low Volatility 56
How calm the share price moves, does not count
Price momentum 0
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 75
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 95/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+18.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+51.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+57.5%
Start year 2020 (pandemic). Over 10 years: +9.1% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.6%
What shareholders gained per year (last 3 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+2.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−9.2%
Dividend (yield on the price)11.8%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−45% → 9%

Watch 1450, get fair value alerts →

Compare Century Sage Scientific with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software - Application · 724 stocks

Beats the industry median on 13/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 71 · Top 25%
Fair Value upside +200.0% · Top 25%
Profitability
Return on equity (12 months) 23.1% · Top 25%
Return on assets 9.5% · Top 25%
Net margin (12 months) 7.3% · Above median
Operating margin (12 months) 14.7% · Above median
Growth and dividend
Revenue growth (quarter YoY) 24.5% · Top 25%
Dividend yield (12 months) 11.8% · Top 25%

Valuation Multiplesvs Software - Application median · lower = cheaper

P/E (12 months) 5.1× · Cheapest 25%
P/B 0.85× · Cheapest 25%
P/S (12 months) 0.28× · Cheapest 25%
Price / free cash flow (fiscal year) 1.3× · Cheapest 25%
EV/EBITDA 0.6× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 28
FUTURE (revenue growth)100 · sector 42
PAST (return on equity)92 · sector 11
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)100 · sector 29

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Adobe Inc ADBE $235.55 $463.72 +97% vs 1450
Salesforce, Inc CRM $194.52 $342.73 +76% vs 1450
Uber Technologies, Inc UBER $68.81 $101.28 +47% vs 1450
Intuit Inc INTU $320.79 $459.14 +43% vs 1450
ServiceNow, Inc NOW $92.90 $102.19 +10% vs 1450
SAP SE SAP €201.50 €173.59 −14% vs 1450
Cadence Design Systems, Inc CDNS $306.97 $225.48 −27% vs 1450
Automatic Data Processing, Inc ADP $308.29 $192.37 −38% vs 1450
Shopify Inc SHOP $141.90 $64.96 −54% vs 1450
Snowflake Inc SNOW $272.94 $74.50 −73% vs 1450

Explore undervalued stocks

More undervalued Technology stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Century Sage Scientific: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Century Sage Scientific Fair Value". https://www.fairvalue-calculator.com/stock/1450

Frequently asked questions

Is Century Sage Scientific (1450) overvalued or undervalued?
As of Nov 18, 2026, our model estimates a fair value of HK$1.14 versus a price of HK$0.3800, about +200% upside (undervalued).
What is the fair value of 1450?
Our model-based fair value for Century Sage Scientific is HK$1.14 (as of Nov 18, 2026), built from audited fundamentals. The current price: HK$0.3800.
What is the quality score of 1450?
Century Sage Scientific has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Century Sage Scientific (1450)?
Our model-based price target is the fair value of HK$1.14 (as of Nov 18, 2026) from 24 valuation models. Cautious scenario HK$0.7953, optimistic scenario HK$1.48. It is a calculation from audited fundamentals, not an analyst target.
What is the Century Sage Scientific stock forecast for 2026?
Our models put fair value at HK$1.14, about +200% upside versus a price of HK$0.3800 (undervalued). Cautious scenario HK$0.7953, optimistic scenario HK$1.48. The calculation is refreshed regularly with new filings.
What is the revenue of Century Sage Scientific (1450)?
Century Sage Scientific reported trailing-twelve-month revenue of about 1.6B CNY (latest available figure, as of Nov 18, 2026).
Does Century Sage Scientific pay a dividend?
Century Sage Scientific currently shows a dividend yield of 11.84% relative to its recent price (as of Nov 18, 2026).
How much is the dividend of Century Sage Scientific (1450) and when is the ex-dividend date?
Century Sage Scientific pays a dividend of HK$0.045 per share a year, a dividend yield of 11.8%. The last ex-dividend date was Jun 24, 2026. The payout ratio is 59.5% of earnings. Free cash flow covers the dividend 6.54 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What is the intrinsic value of Century Sage Scientific (1450)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Century Sage Scientific it is HK$1.14 per share (as of Nov 18, 2026), against a price of HK$0.3800. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Century Sage Scientific stock overvalued or undervalued in 2026?
As of Nov 18, 2026, 1450 trades below its calculated fair value: price HK$0.3800, fair value HK$1.14, a gap of about +200% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 1450?
No. The price is what the market pays today (HK$0.3800); the fair value is what the company's own numbers justify (HK$1.14). For Century Sage Scientific the two are HK$0.7600 per share apart. That gap is exactly why we show both numbers side by side.
How much is Century Sage Scientific worth?
The market values Century Sage Scientific at about HK$534M (market capitalisation, as of Nov 18, 2026). Per share that is HK$0.3800; our models calculate a fair value of HK$1.14 per share.
What do the bullish and bearish scenarios say about 1450?
Our models span a range for Century Sage Scientific: cautious scenario HK$0.7953, base HK$1.14, optimistic HK$1.48 per share (as of Nov 18, 2026, price HK$0.3800). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 1450?
Century Sage Scientific trades at a price-to-earnings ratio of 5.1 (as of Nov 18, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$1.14 is built from several models across several years. Other multiples: P/B 0.9, P/S 0.3, EV/EBITDA 0.6.
How solid is the balance sheet of Century Sage Scientific (1450)?
Balance-sheet figures for Century Sage Scientific (as of Nov 18, 2026): return on equity 23.1%. They feed the Quality Score of 71/100, which measures business quality independently of the share price.
How far is 1450 from its 52-week high?
Century Sage Scientific trades at HK$0.3800, about 66% below its 52-week high of HK$1.13 and at the low of HK$0.3800 (as of Nov 17, 2026). Distance from the high says nothing about value: that is what the fair value of HK$1.14 is for.
Which stocks are comparable to Century Sage Scientific?
From the same area (Technology) we also value SAP SE, Shopify Inc, Salesforce, Inc, ServiceNow, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Century Sage Scientific stock attractive at the current price?
The data as of Nov 18, 2026: price HK$0.3800, calculated fair value HK$1.14 (+200%), Quality Score 71/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 1450 calculated?
We run Century Sage Scientific through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of HK$1.14 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3% above its aggregate fair value. Century Sage Scientific currently trades 67% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Century Sage Scientific (1450)?
The closing price on Nov 17, 2026 was HK$0.3800. Our model-based fair value is HK$1.14, about +200% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Century Sage Scientific right now?
The price is below even our cautious bear case (HK$0.7953). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (71/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (HK$0.7953 to HK$1.48) leaves room in how you read the outcome.
Where does the earnings growth of Century Sage Scientific (1450) come from?
Earnings per share at Century Sage Scientific grew 0.2 % a year from 2014 to 2025. Broken into its drivers: revenue per share +3.0 %, EBIT margin −2.6 %, tax rate −1.4 %, residual (interest, one-offs) +1.4 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Century Sage Scientific

How large is the market capitalisation of Century Sage Scientific (1450)?
The market capitalisation of Century Sage Scientific is HK$534M (≈ $68.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Century Sage Scientific (1450)?
The price-to-sales ratio of Century Sage Scientific is 0.31 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Century Sage Scientific (1450)?
The dividend yield of Century Sage Scientific is 11.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Century Sage Scientific (1450)?
The net margin of Century Sage Scientific is 6.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Century Sage Scientific (1450)?
The return on equity (ROE) of Century Sage Scientific is 23.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Century Sage Scientific (1450)?
On an EBIT basis the return on assets of Century Sage Scientific is 6.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Century Sage Scientific (1450)?
The operating margin of Century Sage Scientific is 14.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Century Sage Scientific (1450)?
Revenue at Century Sage Scientific is growing 24.5% versus a year earlier (3y avg +51.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Century Sage Scientific (1450)?
Earnings per share at Century Sage Scientific are growing 46.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Century Sage Scientific (1450) generate?
The free cash flow of Century Sage Scientific is 351M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Century Sage Scientific (1450) hold?
Century Sage Scientific holds more cash than debt, 255M CNY net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Century Sage Scientific in the live analysis

One click puts Century Sage Scientific on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.